• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

β淀粉样蛋白 42 与健康老年人的认知障碍和主观认知障碍有关。

Amyloid-β₄₂ is associated with cognitive impairment in healthy elderly and subjective cognitive impairment.

机构信息

Institute of Neuroscience and Physiology, The Sahlgrenska Academy at the University of Gothenburg, Mölndal, Sweden.

出版信息

J Alzheimers Dis. 2011;26(1):135-42. doi: 10.3233/JAD-2011-110038.

DOI:10.3233/JAD-2011-110038
PMID:21593572
Abstract

The aim of this study was to predict cognitive performance on the basis of the cerebrospinal fluid (CSF) biomarkers total tau (T-tau) and amyloid-β₄₂ (Aβ₄₂) in controls and patients at various impairment levels. Previous studies have found an association of CSF T-tau levels with cognitive symptoms, but it has been difficult to relate Aβ to cognition, and it has thus been hypothesized that Aβ reaches a plateau level prior to cognitive symptoms. A comprehensive battery of neuropsychological tests was subjected to factor analysis to yield aggregated cognitive domains. Linear regression models were performed for the total sample of the Gothenburg MCI study (n = 435) and for each level of impairment. Aβ₄₂ and T-tau accounted for a significant proportion of performance in all cognitive domains in the total sample. In controls (n = 60) and patients with subjective cognitive impairment (n = 105), Aβ₄₂ predicted a significant proportion of semantic and working memory performance. For patients with mild cognitive impairment (n = 170), T-tau had the most pronounced impact across cognitive domains, and more specifically on episodic memory, visuospatial, and speed/executive performance. For patients with dementia (n = 100), the most pronounced impacts of Aβ₄₂ were found in episodic memory and visuospatial functioning, while T-tau was substantially associated with episodic memory. Our results suggest that cognition is related to CSF biomarkers regardless of impairment level. Aβ₄₂ is associated with cognitive functions from a potentially early to a later disease phase, and T-tau is more indicative of performance in a later disease phase.

摘要

本研究旨在基于脑脊液(CSF)生物标志物总 tau(T-tau)和淀粉样蛋白-β₄₂(Aβ₄₂)预测认知表现,研究对象为不同损伤程度的对照组和患者。先前的研究发现 CSF T-tau 水平与认知症状相关,但 Aβ 与认知的关系一直难以确定,因此有人假设 Aβ 在认知症状出现之前达到平台水平。采用神经心理学综合测试对认知域进行因子分析。对哥德堡轻度认知障碍研究(n = 435)的总样本和每个损伤水平进行线性回归模型分析。Aβ₄₂ 和 T-tau 在总样本的所有认知域中均占表现的显著比例。在对照组(n = 60)和主观认知障碍患者(n = 105)中,Aβ₄₂ 预测了语义和工作记忆表现的显著比例。对于轻度认知障碍患者(n = 170),T-tau 在认知域中具有最显著的影响,尤其是在情景记忆、视空间和速度/执行功能方面。对于痴呆患者(n = 100),Aβ₄₂ 对情景记忆和视空间功能的影响最为显著,而 T-tau 与情景记忆有显著相关性。我们的研究结果表明,认知与 CSF 生物标志物相关,无论损伤程度如何。Aβ₄₂ 与疾病早期到晚期的认知功能相关,而 T-tau 更能反映疾病晚期的表现。

相似文献

1
Amyloid-β₄₂ is associated with cognitive impairment in healthy elderly and subjective cognitive impairment.β淀粉样蛋白 42 与健康老年人的认知障碍和主观认知障碍有关。
J Alzheimers Dis. 2011;26(1):135-42. doi: 10.3233/JAD-2011-110038.
2
Amyloid-β and α-synuclein cerebrospinal fluid biomarkers and cognition in early Parkinson's disease.淀粉样蛋白β和α-突触核蛋白脑脊液生物标志物与早期帕金森病的认知
Parkinsonism Relat Disord. 2015 Jul;21(7):758-64. doi: 10.1016/j.parkreldis.2015.04.027. Epub 2015 May 2.
3
Varying strength of cognitive markers and biomarkers to predict conversion and cognitive decline in an early-stage-enriched mild cognitive impairment sample.在一个早期富集的轻度认知障碍样本中,用于预测转化和认知衰退的认知标志物和生物标志物的不同强度。
J Alzheimers Dis. 2015;44(2):625-33. doi: 10.3233/JAD-141716.
4
Cerebrospinal fluid biomarkers mirror rate of cognitive decline.脑脊液生物标志物反映认知衰退速度。
J Alzheimers Dis. 2013;34(4):949-56. doi: 10.3233/JAD-121960.
5
Associations between Cerebrospinal Fluid Biomarkers and Cognition in Early Untreated Parkinson's Disease.未经治疗的早期帕金森病患者脑脊液生物标志物与认知功能的关联
J Parkinsons Dis. 2015;5(4):783-92. doi: 10.3233/JPD-150682.
6
Tau and Amyloid-β Cerebrospinal Fluid Biomarkers have Differential Relationships with Cognition in Mild Cognitive Impairment.tau蛋白和β淀粉样蛋白脑脊液生物标志物与轻度认知障碍患者的认知功能存在不同关系。
J Alzheimers Dis. 2015;47(4):965-75. doi: 10.3233/JAD-142643.
7
T-Tau is Associated with Objective Memory Decline Over Two Years in Persons Seeking Help for Subjective Cognitive Decline: A Report from the Gothenburg-Oslo MCI Study.在因主观认知衰退寻求帮助的人群中,总tau蛋白与两年内的客观记忆衰退相关:哥德堡-奥斯陆轻度认知障碍研究报告
J Alzheimers Dis. 2015;47(3):619-28. doi: 10.3233/JAD-150109.
8
Chronic depressive symptomatology and CSF amyloid beta and tau levels in mild cognitive impairment.轻度认知障碍中的慢性抑郁症状与脑脊液淀粉样蛋白β和tau水平
Int J Geriatr Psychiatry. 2018 Oct;33(10):1305-1311. doi: 10.1002/gps.4926. Epub 2018 Jun 28.
9
Cerebrospinal fluid levels of β-amyloid 1-42, but not of tau, are fully changed already 5 to 10 years before the onset of Alzheimer dementia.在阿尔茨海默病性痴呆发病前5至10年,脑脊液中β-淀粉样蛋白1-42的水平就已完全改变,而tau蛋白的水平则不然。
Arch Gen Psychiatry. 2012 Jan;69(1):98-106. doi: 10.1001/archgenpsychiatry.2011.155.
10
Interactions between amyloid-β and tau in cerebrospinal fluid of people with mild cognitive impairment and Alzheimer's disease.轻度认知障碍和阿尔茨海默病患者脑脊液中β淀粉样蛋白与tau蛋白的相互作用。
J Alzheimers Dis. 2014;42 Suppl 3:S91-8. doi: 10.3233/JAD-132393.

引用本文的文献

1
Predictive value for cerebrospinal fluid Alzheimer's disease profile of different measures of verbal episodic memory in patients with MCI.不同言语情景记忆测量指标在 MCI 患者中对脑脊液阿尔茨海默病谱的预测价值。
Sci Rep. 2024 May 28;14(1):12235. doi: 10.1038/s41598-024-62604-z.
2
The Challenge of Subjective Cognitive Complaints and Executive Functions in Middle-Aged Adults as a Preclinical Stage of Dementia: A Systematic Review.中年成年人主观认知主诉和执行功能作为痴呆临床前期的挑战:一项系统综述
Geriatrics (Basel). 2022 Mar 8;7(2):30. doi: 10.3390/geriatrics7020030.
3
Accuracy of the Brief Cognitive Screening Battery for diagnosing Alzheimer's disease defined by cerebrospinal fluid biomarkers and AT(N) classification: a case-control study.
简易认知筛查量表对基于脑脊液生物标志物和 AT(N) 分类的阿尔茨海默病诊断的准确性:一项病例对照研究。
Arq Neuropsiquiatr. 2022 Jan;80(1):23-29. doi: 10.1590/0004-282X-ANP-2021-0012.
4
Association of glial and neuronal degeneration markers with Alzheimer's disease cerebrospinal fluid profile and cognitive functions.胶质和神经元退行性标志物与阿尔茨海默病脑脊液特征和认知功能的关联。
Alzheimers Res Ther. 2020 Aug 4;12(1):92. doi: 10.1186/s13195-020-00657-8.
5
Medial temporal lobe white matter pathway variability is associated with individual differences in episodic memory in cognitively normal older adults.内侧颞叶白质通路变异性与认知正常的老年人情景记忆的个体差异相关。
Neurobiol Aging. 2020 Mar;87:78-88. doi: 10.1016/j.neurobiolaging.2019.11.011. Epub 2019 Nov 21.
6
Biomarker-Based Signature of Alzheimer's Disease in Pre-MCI Individuals.基于生物标志物的轻度认知障碍前期个体阿尔茨海默病特征
Brain Sci. 2019 Aug 23;9(9):213. doi: 10.3390/brainsci9090213.
7
Correlation between CSF biomarkers of Alzheimer's disease and global cognition in a psychogeriatric clinic cohort.阿尔茨海默病患者脑脊液生物标志物与精神老年科队列患者总体认知的相关性。
Braz J Psychiatry. 2019 Nov-Dec;41(6):479-484. doi: 10.1590/1516-4446-2018-0296.
8
Subjective Cognitive Decline and Alzheimer's Disease Spectrum Disorder.主观认知衰退与阿尔茨海默病谱系障碍
Dement Neurocogn Disord. 2017 Jun;16(2):40-47. doi: 10.12779/dnd.2017.16.2.40. Epub 2017 Jun 30.
9
Subjective cognitive decline: preclinical manifestation of Alzheimer's disease.主观认知下降:阿尔茨海默病的临床前表现。
Neurol Sci. 2019 Jan;40(1):41-49. doi: 10.1007/s10072-018-3620-y. Epub 2018 Nov 5.
10
The etiological effect of a new low-frequency variant on Mild Cognitive Impairment and Alzheimer's Disease: a population-based study.一种新的低频变异对轻度认知障碍和阿尔茨海默病的病因学影响:一项基于人群的研究。
Aging (Albany NY). 2018 Sep 16;10(9):2316-2337. doi: 10.18632/aging.101548.